LIVN · XBRL financial data

LivaNova financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (LIVN's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	934	1,035	1,022	1,154	1,253	1,388
Cost of goods and services sold	308	329	315	382	383	448
Gross profit	595	706	707	771	871	940
Research and development	153	183	156	194	183	186
Selling, general and administrative	428	472	469	518	526	549
Other operating income (expense)	—	(51)	(30)	(38)	(33)	(6)
Operating income (loss)	(270)	(1)	(77)	(68)	129	199
Interest income	0	0	5	22	30	19
Interest expense	41	50	48	59	63	49
Other income (expense)	—	—	1	1	1	1
Income tax expense (benefit)	(1)	11	11	(99)	25	22
Net income (loss)	(345)	(136)	(86)	18	63	(242)
Earnings per share, basic USD per share	(7.10)	(2.68)	(1.61)	0.33	1.17	(4.45)
Earnings per share, diluted USD per share	(7.10)	(2.68)	(1.61)	0.32	1.16	(4.45)
Weighted average shares, basic millions of shares	49	51	53	54	54	55
Weighted average shares, diluted millions of shares	49	51	53	54	55	55

Fiscal years (LIVN's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	253	208	214	267	429	636
Accounts receivable	184	185	183	215	193	216
Inventory	127	106	129	148	148	165
Prepaid and other current assets	25	36	25	27	32	37
Total current assets	719	679	886	988	1,127	1,102
Property and equipment, net	164	150	147	154	170	243
Right-of-use asset	51	41	36	51	47	56
Goodwill	922	900	769	783	750	793
Total assets	2,411	2,201	2,295	2,430	2,506	2,606
Accounts payable	74	68	74	81	70	97
Accrued liabilities	95	89	76	107	118	95
Current portion of long-term debt	8	227	21	17	77	31
Total current liabilities	309	697	297	335	392	808
Long-term debt	642	10	518	569	550	345
Lease liability, non-current	42	36	30	45	40	48
Total liabilities	1,293	906	1,087	1,152	1,186	1,406
Accumulated deficit	(752)	(898)	(984)	(966)	(903)	(1,146)
Total stockholders' equity	1,119	1,295	1,208	1,278	1,320	1,200
Total liabilities and equity	2,411	2,201	2,295	2,430	2,506	2,606
Common shares outstanding (cover page) millions of shares	49	53	54	54	54	55

Fiscal years (LIVN's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(345)	(136)	(86)	18	63	(242)
Stock-based compensation	35	41	45	36	34	36
Net cash from operating activities	(79)	103	70	75	183	254
Purchases of property and equipment	35	25	27	35	47	81
Net cash from investing activities	(42)	37	(38)	(40)	(48)	(73)
Proceeds from issuing common stock	0	323	0	0	—	—
Share repurchases	0	—	—	—	—	—
Proceeds from long-term debt	887	0	508	50	336	0
Repayments of long-term debt	482	452	224	22	248	281
Net cash from financing activities	311	(181)	280	21	19	(286)
Net change in cash	192	(45)	308	62	146	(88)

SIC 3845 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3845 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
LivaNova	563	393	74*	55.1M	Q3 FY26 10-QSep 30, 2026
Envista Holdings	1,159	692	78*	160.3M	Q3 FY26 10-QOct 2, 2026
Teleflex	300	570	not reported	42.4M	Q2 FY26 10-QJun 30, 2026
Haemonetics	223	339	52	45.5M	Q1 FY27 10-QJun 27, 2026
Dentsply Sirona	239	898	99*	199.4M	Q2 FY26 10-QJun 30, 2026
PROCEPT BioRobotics	218	98	not reported	57.5M	Q3 FY26 10-QSep 30, 2026
Icu Medical	298	552	80*	25.0M	Q2 FY26 10-QJun 30, 2026
Enovis	13	583	75*	57.7M	Q2 FY26 10-QJul 3, 2026
Ufp Technologies	9	174	16*	7.7M	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.